Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
T-Lymphocytes | 53 | 2024 | 10264 | 3.220 |
Why?
|
Clonal Anergy | 24 | 2008 | 169 | 2.970 |
Why?
|
Cord Blood Stem Cell Transplantation | 9 | 2019 | 305 | 2.780 |
Why?
|
rap1 GTP-Binding Proteins | 10 | 2013 | 51 | 1.760 |
Why?
|
Neoplasms | 18 | 2024 | 22365 | 1.320 |
Why?
|
Graft vs Host Disease | 15 | 2019 | 3049 | 1.290 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 12 | 2012 | 317 | 1.220 |
Why?
|
Adaptor Proteins, Signal Transducing | 12 | 2021 | 2906 | 1.220 |
Why?
|
Lymphocyte Activation | 39 | 2024 | 5505 | 1.200 |
Why?
|
Interleukin-7 | 7 | 2015 | 146 | 1.190 |
Why?
|
Virus Activation | 3 | 2019 | 324 | 1.190 |
Why?
|
Tumor Microenvironment | 9 | 2024 | 3948 | 1.160 |
Why?
|
CD4-Positive T-Lymphocytes | 13 | 2015 | 4415 | 1.080 |
Why?
|
T-Lymphocytes, Helper-Inducer | 7 | 2018 | 977 | 1.070 |
Why?
|
T-Lymphocytes, Regulatory | 10 | 2024 | 3114 | 1.060 |
Why?
|
Fetal Blood | 6 | 2019 | 1361 | 1.010 |
Why?
|
Immunotherapy | 11 | 2023 | 4748 | 0.980 |
Why?
|
T-Lymphocyte Subsets | 8 | 2019 | 1815 | 0.900 |
Why?
|
Myelopoiesis | 1 | 2024 | 135 | 0.870 |
Why?
|
Tumor Suppressor Proteins | 12 | 2009 | 2800 | 0.830 |
Why?
|
PTEN Phosphohydrolase | 2 | 2022 | 1120 | 0.830 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2023 | 892 | 0.820 |
Why?
|
Interleukin-17 | 3 | 2013 | 924 | 0.770 |
Why?
|
Signal Transduction | 41 | 2022 | 23642 | 0.760 |
Why?
|
Interleukin-2 | 21 | 2012 | 1895 | 0.740 |
Why?
|
BK Virus | 2 | 2019 | 120 | 0.720 |
Why?
|
Membrane Proteins | 14 | 2021 | 7876 | 0.700 |
Why?
|
Peroxisome Proliferator-Activated Receptors | 1 | 2020 | 61 | 0.700 |
Why?
|
Integrins | 5 | 2021 | 842 | 0.690 |
Why?
|
Myeloid Cells | 3 | 2022 | 839 | 0.680 |
Why?
|
Polyomavirus Infections | 2 | 2019 | 192 | 0.660 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2020 | 224 | 0.640 |
Why?
|
Jurkat Cells | 12 | 2020 | 740 | 0.630 |
Why?
|
Tumor Virus Infections | 2 | 2019 | 437 | 0.630 |
Why?
|
Thymus Gland | 3 | 2014 | 1266 | 0.620 |
Why?
|
Peyer's Patches | 1 | 2018 | 120 | 0.610 |
Why?
|
Hematopoietic Stem Cell Transplantation | 10 | 2019 | 5717 | 0.590 |
Why?
|
Cyclin-Dependent Kinase 2 | 4 | 2014 | 185 | 0.590 |
Why?
|
Herpesvirus 6, Human | 1 | 2018 | 97 | 0.580 |
Why?
|
Antigens, CD | 28 | 2019 | 4035 | 0.580 |
Why?
|
Immune Tolerance | 12 | 2014 | 2322 | 0.570 |
Why?
|
Antigens, Differentiation | 14 | 2010 | 921 | 0.560 |
Why?
|
Killer Cells, Natural | 2 | 2024 | 2211 | 0.550 |
Why?
|
Smad3 Protein | 4 | 2012 | 166 | 0.540 |
Why?
|
Immunologic Memory | 2 | 2024 | 1377 | 0.540 |
Why?
|
cdc25 Phosphatases | 2 | 2012 | 60 | 0.510 |
Why?
|
Immunity | 2 | 2020 | 1003 | 0.510 |
Why?
|
Leukemia-Lymphoma, Adult T-Cell | 4 | 2005 | 168 | 0.510 |
Why?
|
Receptors, Antigen, T-Cell | 17 | 2016 | 2568 | 0.510 |
Why?
|
Phosphorylation | 16 | 2020 | 8314 | 0.510 |
Why?
|
CD8-Positive T-Lymphocytes | 7 | 2024 | 4648 | 0.500 |
Why?
|
Flow Cytometry | 6 | 2021 | 5902 | 0.500 |
Why?
|
Hematopoietic Stem Cells | 4 | 2024 | 3409 | 0.480 |
Why?
|
Stem Cell Factor | 1 | 2015 | 194 | 0.480 |
Why?
|
Animals | 66 | 2024 | 169222 | 0.480 |
Why?
|
Immunoconjugates | 13 | 2002 | 975 | 0.480 |
Why?
|
Colonic Neoplasms | 2 | 2020 | 2540 | 0.480 |
Why?
|
Angiogenesis Inducing Agents | 1 | 2016 | 254 | 0.480 |
Why?
|
ras Proteins | 4 | 2012 | 1054 | 0.470 |
Why?
|
Lymphocyte Function-Associated Antigen-1 | 3 | 2012 | 381 | 0.470 |
Why?
|
S-Phase Kinase-Associated Proteins | 3 | 2012 | 89 | 0.470 |
Why?
|
Cell Adhesion | 8 | 2021 | 3096 | 0.460 |
Why?
|
Immunity, Humoral | 1 | 2018 | 610 | 0.460 |
Why?
|
Oxidation-Reduction | 2 | 2023 | 2227 | 0.460 |
Why?
|
Cell Cycle | 12 | 2009 | 2932 | 0.460 |
Why?
|
Forkhead Transcription Factors | 5 | 2023 | 1625 | 0.460 |
Why?
|
Lipid Metabolism | 2 | 2020 | 1904 | 0.450 |
Why?
|
G1 Phase | 4 | 2012 | 403 | 0.450 |
Why?
|
Lipolysis | 1 | 2015 | 211 | 0.440 |
Why?
|
Tumor Escape | 1 | 2016 | 372 | 0.440 |
Why?
|
B-Lymphocytes | 10 | 2018 | 4791 | 0.440 |
Why?
|
Cell Cycle Proteins | 10 | 2006 | 3443 | 0.430 |
Why?
|
Cell Differentiation | 11 | 2022 | 11665 | 0.430 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2018 | 777 | 0.420 |
Why?
|
Casein Kinase II | 1 | 2013 | 121 | 0.410 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2012 | 76 | 0.410 |
Why?
|
Core Binding Factor Alpha 3 Subunit | 1 | 2012 | 58 | 0.410 |
Why?
|
Glycolysis | 2 | 2024 | 837 | 0.400 |
Why?
|
Autoimmunity | 3 | 2014 | 1361 | 0.400 |
Why?
|
Viremia | 2 | 2019 | 726 | 0.400 |
Why?
|
Cyclin-Dependent Kinases | 7 | 2006 | 661 | 0.390 |
Why?
|
Immunophenotyping | 11 | 2021 | 1863 | 0.390 |
Why?
|
Intracellular Signaling Peptides and Proteins | 3 | 2009 | 2889 | 0.390 |
Why?
|
Phosphatidylinositol 3-Kinases | 7 | 2012 | 2884 | 0.380 |
Why?
|
Receptors, Interleukin-2 | 5 | 2005 | 564 | 0.370 |
Why?
|
Proto-Oncogene Proteins c-akt | 6 | 2012 | 2456 | 0.370 |
Why?
|
Humans | 136 | 2024 | 767991 | 0.370 |
Why?
|
Autoimmune Diseases | 1 | 2023 | 2256 | 0.360 |
Why?
|
Transforming Growth Factor beta | 4 | 2010 | 1996 | 0.360 |
Why?
|
Carrier Proteins | 6 | 2009 | 4937 | 0.350 |
Why?
|
Mice | 40 | 2024 | 82024 | 0.340 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 1 | 2012 | 355 | 0.340 |
Why?
|
Immunity, Innate | 2 | 2021 | 3079 | 0.340 |
Why?
|
Purines | 2 | 2014 | 615 | 0.340 |
Why?
|
Melanoma | 3 | 2020 | 5706 | 0.340 |
Why?
|
HLA-DR7 Antigen | 6 | 1996 | 27 | 0.330 |
Why?
|
Phospholipase C gamma | 1 | 2009 | 131 | 0.330 |
Why?
|
Isoantigens | 6 | 2005 | 562 | 0.330 |
Why?
|
Cells, Cultured | 20 | 2015 | 19017 | 0.320 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2016 | 8637 | 0.320 |
Why?
|
Neoplasm Proteins | 3 | 2015 | 3601 | 0.310 |
Why?
|
Receptors, OX40 | 1 | 2008 | 46 | 0.300 |
Why?
|
Lymphocyte Depletion | 2 | 2008 | 605 | 0.300 |
Why?
|
Cytomegalovirus | 2 | 2010 | 751 | 0.300 |
Why?
|
Clone Cells | 10 | 2010 | 1669 | 0.300 |
Why?
|
Interleukin-1beta | 2 | 2012 | 1027 | 0.300 |
Why?
|
Cell Proliferation | 10 | 2014 | 10470 | 0.300 |
Why?
|
Adoptive Transfer | 2 | 2010 | 825 | 0.300 |
Why?
|
Proto-Oncogene Proteins | 8 | 2005 | 4525 | 0.290 |
Why?
|
Antibodies, Monoclonal | 8 | 2023 | 9252 | 0.290 |
Why?
|
Hematologic Neoplasms | 2 | 2016 | 1907 | 0.290 |
Why?
|
MAP Kinase Signaling System | 3 | 2012 | 1492 | 0.280 |
Why?
|
Enzyme Activation | 6 | 2020 | 3587 | 0.280 |
Why?
|
Fatty Acids | 1 | 2015 | 1811 | 0.280 |
Why?
|
Phagocytosis | 4 | 2024 | 1530 | 0.270 |
Why?
|
Glioma | 2 | 2022 | 3503 | 0.270 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 9 | 2008 | 1642 | 0.270 |
Why?
|
Mice, Inbred C57BL | 12 | 2024 | 22381 | 0.270 |
Why?
|
Down-Regulation | 5 | 2004 | 2936 | 0.270 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 2 | 2015 | 1437 | 0.260 |
Why?
|
Granzymes | 4 | 2024 | 277 | 0.260 |
Why?
|
Cell Adhesion Molecules | 3 | 2004 | 1613 | 0.260 |
Why?
|
Transcription, Genetic | 10 | 2012 | 7612 | 0.260 |
Why?
|
COS Cells | 5 | 2020 | 1135 | 0.250 |
Why?
|
Growth Inhibitors | 1 | 2006 | 375 | 0.250 |
Why?
|
Integrin alpha Chains | 1 | 2005 | 93 | 0.240 |
Why?
|
Proto-Oncogene Proteins c-fyn | 3 | 2020 | 114 | 0.240 |
Why?
|
Mitogen-Activated Protein Kinases | 7 | 2005 | 1244 | 0.240 |
Why?
|
Th2 Cells | 3 | 2008 | 1076 | 0.240 |
Why?
|
Interleukin-10 | 2 | 2001 | 1183 | 0.240 |
Why?
|
Cyclic AMP | 3 | 2007 | 1471 | 0.240 |
Why?
|
Cytoskeleton | 1 | 2009 | 1179 | 0.230 |
Why?
|
Protein Multimerization | 2 | 2020 | 965 | 0.230 |
Why?
|
Interphase | 1 | 2004 | 226 | 0.230 |
Why?
|
Interferon-alpha | 5 | 1991 | 910 | 0.230 |
Why?
|
Dendritic Cells | 8 | 2024 | 2745 | 0.220 |
Why?
|
Brain Neoplasms | 3 | 2023 | 9116 | 0.220 |
Why?
|
Cytokines | 11 | 2019 | 7450 | 0.220 |
Why?
|
Contractile Proteins | 1 | 2004 | 240 | 0.220 |
Why?
|
Transplantation, Homologous | 5 | 2014 | 4833 | 0.210 |
Why?
|
Cytomegalovirus Infections | 1 | 2010 | 836 | 0.210 |
Why?
|
Epigenesis, Genetic | 1 | 2016 | 3834 | 0.210 |
Why?
|
Apoptosis | 11 | 2019 | 9521 | 0.210 |
Why?
|
ADP-Ribosylation Factors | 1 | 2003 | 131 | 0.210 |
Why?
|
Lung | 1 | 2021 | 10094 | 0.210 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2022 | 121 | 0.210 |
Why?
|
Transfection | 10 | 2007 | 5757 | 0.200 |
Why?
|
Lymphocytes | 2 | 2010 | 2614 | 0.200 |
Why?
|
Glioblastoma | 3 | 2023 | 3463 | 0.200 |
Why?
|
DNA Methylation | 1 | 2016 | 4426 | 0.200 |
Why?
|
Desensitization, Immunologic | 1 | 2008 | 546 | 0.200 |
Why?
|
Retinoblastoma Protein | 4 | 2012 | 671 | 0.200 |
Why?
|
src Homology Domains | 2 | 2020 | 361 | 0.190 |
Why?
|
Phosphoproteins | 4 | 2012 | 2450 | 0.190 |
Why?
|
Mice, Transgenic | 7 | 2020 | 9556 | 0.190 |
Why?
|
Phosphogluconate Dehydrogenase | 1 | 2021 | 22 | 0.190 |
Why?
|
Tumor Necrosis Factor-alpha | 6 | 2009 | 4351 | 0.180 |
Why?
|
Receptors, Immunologic | 2 | 2019 | 1418 | 0.180 |
Why?
|
Cell Nucleus | 2 | 2007 | 2881 | 0.180 |
Why?
|
Inflammation | 1 | 2020 | 10871 | 0.180 |
Why?
|
Gene Expression Regulation, Leukemic | 2 | 2001 | 658 | 0.180 |
Why?
|
Remission Induction | 8 | 2016 | 2409 | 0.170 |
Why?
|
Microfilament Proteins | 2 | 2004 | 1133 | 0.170 |
Why?
|
Allergens | 1 | 2008 | 1434 | 0.170 |
Why?
|
Lymphocyte Culture Test, Mixed | 8 | 2007 | 510 | 0.170 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2023 | 594 | 0.160 |
Why?
|
Brain Edema | 1 | 2023 | 601 | 0.160 |
Why?
|
Membrane Glycoproteins | 13 | 2002 | 3710 | 0.160 |
Why?
|
Protein-Tyrosine Kinases | 6 | 2003 | 2428 | 0.160 |
Why?
|
Protein Structure, Tertiary | 5 | 2013 | 3771 | 0.160 |
Why?
|
Mice, Knockout | 8 | 2024 | 14486 | 0.160 |
Why?
|
Macrophage Activation | 1 | 2002 | 557 | 0.160 |
Why?
|
Antigen Presentation | 5 | 2024 | 1251 | 0.160 |
Why?
|
Tyrosine | 2 | 2019 | 1427 | 0.160 |
Why?
|
Foscarnet | 1 | 2018 | 36 | 0.160 |
Why?
|
Cancer Vaccines | 3 | 2016 | 1041 | 0.150 |
Why?
|
Hypersensitivity | 1 | 2008 | 1168 | 0.150 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2013 | 2442 | 0.150 |
Why?
|
Reactive Oxygen Species | 2 | 2023 | 2149 | 0.150 |
Why?
|
Histocompatibility Antigens Class II | 4 | 2024 | 1441 | 0.150 |
Why?
|
Immunologic Factors | 2 | 2022 | 1594 | 0.150 |
Why?
|
Microtubule-Associated Proteins | 2 | 2000 | 1074 | 0.150 |
Why?
|
Ubiquitin | 2 | 2013 | 843 | 0.150 |
Why?
|
Antigen-Presenting Cells | 5 | 2010 | 960 | 0.150 |
Why?
|
Coculture Techniques | 3 | 2014 | 1340 | 0.140 |
Why?
|
Up-Regulation | 5 | 2012 | 4146 | 0.140 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2007 | 2846 | 0.140 |
Why?
|
Chimerism | 1 | 2018 | 156 | 0.140 |
Why?
|
Neoplastic Stem Cells | 4 | 2004 | 1351 | 0.140 |
Why?
|
Gene Expression Regulation | 8 | 2013 | 11930 | 0.140 |
Why?
|
3T3 Cells | 7 | 1998 | 1084 | 0.140 |
Why?
|
Protein Kinase Inhibitors | 2 | 2014 | 5694 | 0.140 |
Why?
|
Tuberculosis, Pulmonary | 2 | 2002 | 843 | 0.140 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 4 | 2011 | 474 | 0.140 |
Why?
|
Cell Line, Tumor | 7 | 2024 | 17128 | 0.140 |
Why?
|
Cell Line | 9 | 2012 | 15597 | 0.140 |
Why?
|
Disease-Free Survival | 4 | 2016 | 6843 | 0.140 |
Why?
|
Immunosuppressive Agents | 4 | 2018 | 4205 | 0.140 |
Why?
|
Interleukin-4 | 7 | 2008 | 1156 | 0.140 |
Why?
|
Hodgkin Disease | 8 | 2004 | 1383 | 0.140 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 4 | 2011 | 478 | 0.140 |
Why?
|
Apoptosis Regulatory Proteins | 3 | 2019 | 1150 | 0.140 |
Why?
|
Protein Kinases | 3 | 2008 | 1610 | 0.130 |
Why?
|
Angiopoietin-1 | 1 | 2016 | 133 | 0.130 |
Why?
|
Antineoplastic Agents | 3 | 2016 | 13658 | 0.130 |
Why?
|
Thrombomodulin | 1 | 2016 | 107 | 0.130 |
Why?
|
Germinal Center | 1 | 2018 | 380 | 0.130 |
Why?
|
Cyclins | 4 | 2002 | 605 | 0.130 |
Why?
|
Gangliosides | 1 | 1996 | 132 | 0.130 |
Why?
|
Antioxidants | 1 | 2023 | 1674 | 0.130 |
Why?
|
Mucin-1 | 2 | 2010 | 537 | 0.130 |
Why?
|
Angiopoietin-2 | 1 | 2016 | 186 | 0.120 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2004 | 1560 | 0.120 |
Why?
|
Immunity, Mucosal | 1 | 2018 | 498 | 0.120 |
Why?
|
Skin Neoplasms | 1 | 2014 | 5861 | 0.120 |
Why?
|
Carnitine O-Palmitoyltransferase | 1 | 2015 | 82 | 0.120 |
Why?
|
Guanine | 5 | 1996 | 280 | 0.120 |
Why?
|
Talin | 3 | 2013 | 47 | 0.120 |
Why?
|
Antigens, Differentiation, B-Lymphocyte | 3 | 2004 | 318 | 0.120 |
Why?
|
Lymphoma, Non-Hodgkin | 4 | 1999 | 1374 | 0.120 |
Why?
|
DNA, Viral | 2 | 2019 | 2201 | 0.120 |
Why?
|
Platelet Glycoprotein GPIIb-IIIa Complex | 2 | 2008 | 577 | 0.120 |
Why?
|
Actins | 4 | 2007 | 2064 | 0.120 |
Why?
|
Macrophages | 4 | 2023 | 5799 | 0.120 |
Why?
|
Proteins | 3 | 2007 | 6009 | 0.120 |
Why?
|
Bone Marrow Transplantation | 2 | 1999 | 2710 | 0.110 |
Why?
|
Female | 35 | 2024 | 397113 | 0.110 |
Why?
|
Recurrence | 3 | 2016 | 8507 | 0.110 |
Why?
|
Treatment Outcome | 10 | 2020 | 65364 | 0.110 |
Why?
|
Pseudopodia | 2 | 2004 | 167 | 0.110 |
Why?
|
HLA-B7 Antigen | 1 | 1993 | 48 | 0.110 |
Why?
|
RNA Splicing | 1 | 2018 | 905 | 0.110 |
Why?
|
Interferon-gamma | 7 | 2014 | 3159 | 0.110 |
Why?
|
Recombinant Proteins | 9 | 2007 | 6515 | 0.110 |
Why?
|
Lymphopoiesis | 1 | 2014 | 133 | 0.110 |
Why?
|
Transcriptional Activation | 2 | 2012 | 1752 | 0.110 |
Why?
|
Cell Separation | 2 | 2010 | 1729 | 0.110 |
Why?
|
Ligands | 6 | 2021 | 3284 | 0.110 |
Why?
|
GTP-Binding Proteins | 1 | 1997 | 948 | 0.110 |
Why?
|
Enzyme Stability | 1 | 2013 | 219 | 0.100 |
Why?
|
Phosphatidylinositol Phosphates | 2 | 2012 | 201 | 0.100 |
Why?
|
Vaccination | 4 | 2016 | 3437 | 0.100 |
Why?
|
Receptors, Antigen, B-Cell | 3 | 2008 | 547 | 0.100 |
Why?
|
Glucose | 1 | 2004 | 4351 | 0.100 |
Why?
|
Male | 32 | 2024 | 364641 | 0.100 |
Why?
|
RNA, Messenger | 9 | 2013 | 12797 | 0.100 |
Why?
|
Molecular Structure | 1 | 2016 | 1883 | 0.100 |
Why?
|
Perforin | 1 | 2012 | 167 | 0.100 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2016 | 633 | 0.100 |
Why?
|
Adult | 28 | 2019 | 223583 | 0.100 |
Why?
|
Growth Substances | 1 | 1994 | 759 | 0.100 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2016 | 1168 | 0.100 |
Why?
|
Tissue Donors | 3 | 2018 | 2381 | 0.100 |
Why?
|
WT1 Proteins | 2 | 2014 | 183 | 0.100 |
Why?
|
Protein Binding | 2 | 2020 | 9343 | 0.100 |
Why?
|
Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2012 | 151 | 0.090 |
Why?
|
Procarbazine | 4 | 2004 | 172 | 0.090 |
Why?
|
Genetic Predisposition to Disease | 1 | 2013 | 18062 | 0.090 |
Why?
|
Phosphotyrosine | 2 | 2005 | 458 | 0.090 |
Why?
|
Cell Survival | 7 | 2011 | 5772 | 0.090 |
Why?
|
HEK293 Cells | 1 | 2020 | 4289 | 0.090 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 2 | 2004 | 635 | 0.090 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 2 | 2004 | 897 | 0.090 |
Why?
|
Middle Aged | 26 | 2019 | 223422 | 0.090 |
Why?
|
Gene Expression | 5 | 2012 | 7597 | 0.090 |
Why?
|
Dacarbazine | 5 | 2004 | 552 | 0.090 |
Why?
|
MAP Kinase Kinase 4 | 1 | 2010 | 147 | 0.090 |
Why?
|
Antibodies, Viral | 2 | 2019 | 3216 | 0.090 |
Why?
|
Transplantation Conditioning | 3 | 2019 | 1601 | 0.090 |
Why?
|
Guanosine Triphosphate | 2 | 2003 | 315 | 0.090 |
Why?
|
Recombinant Fusion Proteins | 7 | 2006 | 3740 | 0.080 |
Why?
|
Transplantation, Heterologous | 3 | 2021 | 2392 | 0.080 |
Why?
|
Histocompatibility | 2 | 2002 | 321 | 0.080 |
Why?
|
Genes, bcl-2 | 2 | 2001 | 119 | 0.080 |
Why?
|
Phosphatidylinositol 4,5-Diphosphate | 1 | 2009 | 123 | 0.080 |
Why?
|
Lymphoma, Follicular | 2 | 2008 | 460 | 0.080 |
Why?
|
Sirolimus | 2 | 2010 | 1538 | 0.080 |
Why?
|
Aged | 24 | 2019 | 171446 | 0.080 |
Why?
|
Kinetics | 2 | 2015 | 6328 | 0.080 |
Why?
|
Cell Membrane | 2 | 2012 | 3657 | 0.080 |
Why?
|
Cell Movement | 2 | 2011 | 5209 | 0.080 |
Why?
|
Models, Animal | 2 | 2009 | 2120 | 0.080 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2012 | 706 | 0.080 |
Why?
|
Viral Load | 1 | 2018 | 3396 | 0.080 |
Why?
|
Oligonucleotides, Antisense | 2 | 2001 | 462 | 0.080 |
Why?
|
Young Adult | 4 | 2019 | 60048 | 0.080 |
Why?
|
Blood Cells | 2 | 2008 | 309 | 0.080 |
Why?
|
Endothelial Cells | 1 | 2021 | 3589 | 0.080 |
Why?
|
ZAP-70 Protein-Tyrosine Kinase | 2 | 2000 | 69 | 0.080 |
Why?
|
Spleen | 2 | 2010 | 2295 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 3 | 2001 | 1405 | 0.080 |
Why?
|
Amino Acid Sequence | 8 | 2004 | 13420 | 0.070 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 1997 | 1901 | 0.070 |
Why?
|
Cell Division | 5 | 2004 | 4473 | 0.070 |
Why?
|
Molecular Sequence Data | 9 | 2004 | 17617 | 0.070 |
Why?
|
1-Methyl-3-isobutylxanthine | 2 | 2007 | 100 | 0.070 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2010 | 694 | 0.070 |
Why?
|
Intercellular Adhesion Molecule-1 | 2 | 2006 | 1134 | 0.070 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 4576 | 0.070 |
Why?
|
Sequence Homology, Amino Acid | 4 | 2004 | 2748 | 0.070 |
Why?
|
Protein Transport | 2 | 2009 | 1951 | 0.070 |
Why?
|
Precipitin Tests | 2 | 2004 | 816 | 0.070 |
Why?
|
Tumor Cells, Cultured | 7 | 2008 | 6119 | 0.070 |
Why?
|
Cell Count | 1 | 2010 | 1831 | 0.070 |
Why?
|
CDC2-CDC28 Kinases | 1 | 2006 | 111 | 0.070 |
Why?
|
Vaccines, DNA | 1 | 2008 | 279 | 0.070 |
Why?
|
Genes, cdc | 1 | 2006 | 113 | 0.070 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2007 | 213 | 0.070 |
Why?
|
Cysteine Endopeptidases | 2 | 2000 | 542 | 0.060 |
Why?
|
Disease Progression | 2 | 2022 | 13665 | 0.060 |
Why?
|
Glutathione Transferase | 2 | 2004 | 565 | 0.060 |
Why?
|
SKP Cullin F-Box Protein Ligases | 1 | 2006 | 174 | 0.060 |
Why?
|
Epitopes | 2 | 2007 | 2526 | 0.060 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2008 | 587 | 0.060 |
Why?
|
Cullin Proteins | 1 | 2006 | 180 | 0.060 |
Why?
|
Interleukins | 2 | 2004 | 796 | 0.060 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 2 | 1998 | 230 | 0.060 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2016 | 3514 | 0.060 |
Why?
|
Mice, Inbred BALB C | 6 | 2006 | 6231 | 0.060 |
Why?
|
Molecular Targeted Therapy | 1 | 2016 | 2824 | 0.060 |
Why?
|
CHO Cells | 6 | 2008 | 1379 | 0.060 |
Why?
|
Two-Hybrid System Techniques | 1 | 2006 | 464 | 0.060 |
Why?
|
Oligonucleotides | 1 | 2008 | 563 | 0.060 |
Why?
|
Profilins | 1 | 2004 | 65 | 0.060 |
Why?
|
Receptor, Notch1 | 1 | 2008 | 518 | 0.060 |
Why?
|
Brain | 2 | 2024 | 27366 | 0.060 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2008 | 384 | 0.060 |
Why?
|
Vidarabine | 2 | 2019 | 337 | 0.060 |
Why?
|
Lymph Nodes | 4 | 2010 | 3472 | 0.060 |
Why?
|
Immunoblotting | 2 | 2004 | 1647 | 0.060 |
Why?
|
Glucose Transporter Type 1 | 1 | 2004 | 186 | 0.060 |
Why?
|
Melphalan | 2 | 2019 | 421 | 0.060 |
Why?
|
Cricetinae | 6 | 2008 | 2423 | 0.060 |
Why?
|
Monomeric GTP-Binding Proteins | 1 | 2005 | 199 | 0.060 |
Why?
|
DNA Primers | 2 | 2007 | 2827 | 0.060 |
Why?
|
Bone Marrow Neoplasms | 1 | 2004 | 101 | 0.060 |
Why?
|
RNA Interference | 1 | 2012 | 2830 | 0.060 |
Why?
|
Trans-Activators | 2 | 2005 | 2857 | 0.060 |
Why?
|
Interferon Type I | 1 | 1988 | 569 | 0.060 |
Why?
|
Receptors, Interleukin | 1 | 2004 | 243 | 0.050 |
Why?
|
Cambodia | 2 | 2002 | 185 | 0.050 |
Why?
|
Binding Sites | 3 | 2006 | 6022 | 0.050 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 3813 | 0.050 |
Why?
|
Multivariate Analysis | 2 | 2015 | 12075 | 0.050 |
Why?
|
HeLa Cells | 2 | 2006 | 3074 | 0.050 |
Why?
|
Tuberculin Test | 2 | 2002 | 205 | 0.050 |
Why?
|
Prognosis | 7 | 2015 | 29979 | 0.050 |
Why?
|
Promoter Regions, Genetic | 2 | 2006 | 5798 | 0.050 |
Why?
|
Receptors, Transferrin | 1 | 2004 | 300 | 0.050 |
Why?
|
Monosaccharide Transport Proteins | 1 | 2004 | 437 | 0.050 |
Why?
|
Proline | 1 | 2004 | 455 | 0.050 |
Why?
|
Luciferases | 1 | 2004 | 714 | 0.050 |
Why?
|
Peptides | 2 | 2008 | 4354 | 0.050 |
Why?
|
Glycogen Synthase Kinases | 1 | 2002 | 40 | 0.050 |
Why?
|
Models, Biological | 5 | 2013 | 9493 | 0.050 |
Why?
|
S Phase | 2 | 2002 | 424 | 0.050 |
Why?
|
Receptor-CD3 Complex, Antigen, T-Cell | 1 | 2002 | 67 | 0.050 |
Why?
|
Fibronectins | 1 | 2006 | 722 | 0.050 |
Why?
|
Protein Interaction Mapping | 1 | 2006 | 622 | 0.050 |
Why?
|
Amino Acid Motifs | 1 | 2004 | 930 | 0.050 |
Why?
|
MAP Kinase Kinase 2 | 1 | 2002 | 92 | 0.050 |
Why?
|
Blood Proteins | 2 | 2012 | 1191 | 0.050 |
Why?
|
Depression, Chemical | 1 | 2001 | 186 | 0.050 |
Why?
|
Obesity | 1 | 2024 | 13091 | 0.050 |
Why?
|
Enzyme Inhibitors | 2 | 2004 | 3726 | 0.050 |
Why?
|
Granulocytes | 1 | 2023 | 551 | 0.050 |
Why?
|
Smad2 Protein | 1 | 2001 | 144 | 0.050 |
Why?
|
6-Aminonicotinamide | 1 | 2021 | 8 | 0.050 |
Why?
|
Transplantation Tolerance | 1 | 2006 | 633 | 0.050 |
Why?
|
Bone Marrow | 4 | 1997 | 2935 | 0.050 |
Why?
|
Transplantation, Autologous | 2 | 2013 | 2120 | 0.050 |
Why?
|
Membrane Potentials | 1 | 2004 | 1091 | 0.050 |
Why?
|
Flavonoids | 1 | 2004 | 447 | 0.050 |
Why?
|
Hypersensitivity, Delayed | 2 | 2000 | 491 | 0.050 |
Why?
|
Lectins, C-Type | 1 | 2004 | 594 | 0.050 |
Why?
|
Cyclosporine | 2 | 1994 | 777 | 0.050 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2016 | 3626 | 0.050 |
Why?
|
bcl-Associated Death Protein | 2 | 1998 | 102 | 0.040 |
Why?
|
Drug Synergism | 2 | 2004 | 1760 | 0.040 |
Why?
|
Smad4 Protein | 1 | 2001 | 193 | 0.040 |
Why?
|
Pentose Phosphate Pathway | 1 | 2021 | 126 | 0.040 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2002 | 492 | 0.040 |
Why?
|
NF-kappa B | 1 | 2009 | 2493 | 0.040 |
Why?
|
DNA-Binding Proteins | 3 | 2010 | 9614 | 0.040 |
Why?
|
Blood Platelets | 2 | 2008 | 2479 | 0.040 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2002 | 330 | 0.040 |
Why?
|
DNA Fragmentation | 2 | 1997 | 240 | 0.040 |
Why?
|
CD40 Ligand | 1 | 2002 | 528 | 0.040 |
Why?
|
Antigens, Neoplasm | 3 | 2016 | 1997 | 0.040 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2023 | 486 | 0.040 |
Why?
|
Janus Kinase 3 | 2 | 2003 | 75 | 0.040 |
Why?
|
Blood Group Incompatibility | 1 | 2001 | 134 | 0.040 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2002 | 414 | 0.040 |
Why?
|
Cyclin D2 | 1 | 2000 | 97 | 0.040 |
Why?
|
Th1 Cells | 2 | 2002 | 1042 | 0.040 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2004 | 1656 | 0.040 |
Why?
|
Liposomes | 1 | 2023 | 790 | 0.040 |
Why?
|
T-Lymphocytes, Cytotoxic | 2 | 1997 | 1801 | 0.040 |
Why?
|
bcl-2-Associated X Protein | 2 | 1998 | 281 | 0.040 |
Why?
|
GTP Phosphohydrolases | 1 | 2003 | 525 | 0.040 |
Why?
|
Tetradecanoylphorbol Acetate | 2 | 2006 | 826 | 0.040 |
Why?
|
Mitochondria | 2 | 2021 | 3681 | 0.040 |
Why?
|
bcl-X Protein | 2 | 1998 | 412 | 0.040 |
Why?
|
DNA Repair | 3 | 1996 | 2050 | 0.040 |
Why?
|
Listeria monocytogenes | 1 | 2021 | 246 | 0.040 |
Why?
|
Neoplasm Staging | 9 | 2004 | 11221 | 0.040 |
Why?
|
Antigens, Surface | 2 | 2001 | 1617 | 0.040 |
Why?
|
Whole-Body Irradiation | 1 | 2019 | 435 | 0.040 |
Why?
|
Acute Disease | 1 | 2009 | 7241 | 0.040 |
Why?
|
Superoxide Dismutase | 1 | 2021 | 596 | 0.040 |
Why?
|
Ubiquitins | 1 | 2000 | 366 | 0.040 |
Why?
|
rap GTP-Binding Proteins | 1 | 1997 | 24 | 0.040 |
Why?
|
Substrate Specificity | 1 | 2002 | 1750 | 0.040 |
Why?
|
ras Guanine Nucleotide Exchange Factors | 1 | 1997 | 34 | 0.040 |
Why?
|
Tacrolimus | 2 | 2010 | 750 | 0.040 |
Why?
|
Lymphotoxin-alpha | 2 | 1995 | 94 | 0.040 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2024 | 1361 | 0.040 |
Why?
|
Preleukemia | 1 | 1997 | 34 | 0.040 |
Why?
|
Immunoglobulin G | 2 | 2008 | 4564 | 0.040 |
Why?
|
Base Sequence | 2 | 2007 | 12418 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-cbl | 1 | 1997 | 120 | 0.040 |
Why?
|
Receptor Aggregation | 2 | 1993 | 72 | 0.030 |
Why?
|
Lymphatic Diseases | 2 | 2001 | 318 | 0.030 |
Why?
|
Leukemia, B-Cell | 1 | 1997 | 86 | 0.030 |
Why?
|
Fas Ligand Protein | 1 | 1997 | 216 | 0.030 |
Why?
|
Genes, Tumor Suppressor | 1 | 2001 | 1059 | 0.030 |
Why?
|
Survival Rate | 2 | 2009 | 12828 | 0.030 |
Why?
|
Caspase 1 | 1 | 1997 | 227 | 0.030 |
Why?
|
Protein Conformation | 1 | 2004 | 3956 | 0.030 |
Why?
|
Vidarabine Phosphate | 1 | 1996 | 11 | 0.030 |
Why?
|
Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 1 | 1996 | 93 | 0.030 |
Why?
|
DNA | 4 | 2003 | 7213 | 0.030 |
Why?
|
Multienzyme Complexes | 1 | 2000 | 664 | 0.030 |
Why?
|
Antigens, Tumor-Associated, Carbohydrate | 1 | 1996 | 138 | 0.030 |
Why?
|
Semaphorins | 1 | 1996 | 96 | 0.030 |
Why?
|
Rats | 6 | 2023 | 23751 | 0.030 |
Why?
|
Antibodies, Bacterial | 1 | 2002 | 1478 | 0.030 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2000 | 564 | 0.030 |
Why?
|
Vitamin D | 1 | 2010 | 3311 | 0.030 |
Why?
|
Disease Models, Animal | 2 | 2023 | 18344 | 0.030 |
Why?
|
Dimerization | 1 | 1997 | 887 | 0.030 |
Why?
|
Transcription Factors | 2 | 2006 | 12165 | 0.030 |
Why?
|
Microglia | 1 | 2024 | 1376 | 0.030 |
Why?
|
Cricetulus | 2 | 2008 | 812 | 0.030 |
Why?
|
Cloning, Molecular | 3 | 1998 | 4168 | 0.030 |
Why?
|
Inflammation Mediators | 1 | 2024 | 1892 | 0.030 |
Why?
|
Adjuvants, Immunologic | 1 | 2000 | 998 | 0.030 |
Why?
|
Clinical Trials as Topic | 2 | 2008 | 8052 | 0.030 |
Why?
|
Multiple Myeloma | 1 | 2013 | 5196 | 0.030 |
Why?
|
Burkitt Lymphoma | 1 | 1997 | 338 | 0.030 |
Why?
|
Paraproteins | 1 | 1994 | 38 | 0.030 |
Why?
|
Mitogens | 2 | 2010 | 229 | 0.030 |
Why?
|
Leukocytes | 3 | 1994 | 2035 | 0.030 |
Why?
|
Green Fluorescent Proteins | 2 | 2012 | 2065 | 0.030 |
Why?
|
Bleomycin | 3 | 2004 | 492 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2022 | 2040 | 0.030 |
Why?
|
Monocytes | 1 | 2023 | 2605 | 0.030 |
Why?
|
Receptors, Cytokine | 1 | 1995 | 258 | 0.030 |
Why?
|
Vinblastine | 3 | 2004 | 487 | 0.030 |
Why?
|
Interleukin-1 | 1 | 1997 | 1252 | 0.030 |
Why?
|
Genetic Vectors | 1 | 2003 | 3402 | 0.030 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 1997 | 572 | 0.030 |
Why?
|
Receptors, Lymphocyte Homing | 1 | 1993 | 141 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 5 | 2013 | 11873 | 0.030 |
Why?
|
Escherichia coli | 1 | 2006 | 4215 | 0.030 |
Why?
|
Calcineurin | 1 | 1994 | 235 | 0.030 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2000 | 1319 | 0.030 |
Why?
|
Graft Rejection | 1 | 2006 | 4492 | 0.030 |
Why?
|
Calmodulin-Binding Proteins | 1 | 1994 | 238 | 0.030 |
Why?
|
O(6)-Methylguanine-DNA Methyltransferase | 4 | 1996 | 82 | 0.030 |
Why?
|
Phosphoprotein Phosphatases | 1 | 1994 | 327 | 0.030 |
Why?
|
Epirubicin | 2 | 2004 | 82 | 0.030 |
Why?
|
Mice, SCID | 2 | 2011 | 2627 | 0.030 |
Why?
|
Electroporation | 1 | 1993 | 239 | 0.030 |
Why?
|
Transplantation Immunology | 1 | 1994 | 537 | 0.030 |
Why?
|
Waldenstrom Macroglobulinemia | 1 | 2001 | 1077 | 0.030 |
Why?
|
HL-60 Cells | 1 | 2013 | 364 | 0.020 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 1996 | 646 | 0.020 |
Why?
|
Macrophage-1 Antigen | 1 | 2013 | 286 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 2000 | 1966 | 0.020 |
Why?
|
Neoplasm, Residual | 1 | 2016 | 1014 | 0.020 |
Why?
|
Leukemia, Hairy Cell | 1 | 1991 | 82 | 0.020 |
Why?
|
Immune System | 1 | 2016 | 799 | 0.020 |
Why?
|
Mycobacterium tuberculosis | 1 | 2002 | 1930 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-vav | 1 | 2011 | 91 | 0.020 |
Why?
|
Vincristine | 3 | 2004 | 1040 | 0.020 |
Why?
|
Reference Values | 2 | 1997 | 4938 | 0.020 |
Why?
|
Major Histocompatibility Complex | 1 | 1993 | 877 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2004 | 15442 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2022 | 2543 | 0.020 |
Why?
|
Thrombocytosis | 1 | 1991 | 88 | 0.020 |
Why?
|
Mechlorethamine | 2 | 2004 | 129 | 0.020 |
Why?
|
Methyltransferases | 4 | 1996 | 373 | 0.020 |
Why?
|
Genes, T-Cell Receptor beta | 1 | 2010 | 70 | 0.020 |
Why?
|
Splenectomy | 1 | 1991 | 392 | 0.020 |
Why?
|
rhoA GTP-Binding Protein | 1 | 2011 | 235 | 0.020 |
Why?
|
Complement System Proteins | 1 | 2013 | 738 | 0.020 |
Why?
|
Thrombocythemia, Essential | 1 | 1991 | 114 | 0.020 |
Why?
|
Placenta | 1 | 2018 | 1725 | 0.020 |
Why?
|
Cell Fusion | 1 | 2010 | 294 | 0.020 |
Why?
|
Tuberculosis | 1 | 2002 | 2029 | 0.020 |
Why?
|
Time Factors | 3 | 2004 | 40214 | 0.020 |
Why?
|
Antilymphocyte Serum | 1 | 2010 | 490 | 0.020 |
Why?
|
Alternative Splicing | 1 | 1993 | 1104 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2013 | 1605 | 0.020 |
Why?
|
GTPase-Activating Proteins | 1 | 2011 | 468 | 0.020 |
Why?
|
Crystallography, X-Ray | 1 | 2012 | 1951 | 0.020 |
Why?
|
Leukocyte Count | 2 | 1991 | 1609 | 0.020 |
Why?
|
Receptor, PAR-1 | 1 | 2008 | 109 | 0.020 |
Why?
|
Leukemia | 2 | 2010 | 1519 | 0.020 |
Why?
|
DNA, Neoplasm | 1 | 1993 | 1742 | 0.020 |
Why?
|
Lymphoma, B-Cell | 1 | 1994 | 945 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2011 | 2014 | 0.020 |
Why?
|
Immunity, Cellular | 1 | 2013 | 1561 | 0.020 |
Why?
|
Cell Polarity | 1 | 2010 | 639 | 0.020 |
Why?
|
Influenza Vaccines | 1 | 1994 | 780 | 0.020 |
Why?
|
Phytohemagglutinins | 2 | 1996 | 165 | 0.020 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2010 | 1353 | 0.020 |
Why?
|
Species Specificity | 3 | 1996 | 2415 | 0.020 |
Why?
|
NFATC Transcription Factors | 1 | 2008 | 393 | 0.020 |
Why?
|
Fluorescence | 1 | 2008 | 757 | 0.020 |
Why?
|
Autoantibodies | 1 | 1994 | 2117 | 0.020 |
Why?
|
Prednisone | 2 | 2004 | 1567 | 0.020 |
Why?
|
Radiotherapy Dosage | 2 | 2004 | 2916 | 0.020 |
Why?
|
Carcinoma | 1 | 1996 | 2330 | 0.020 |
Why?
|
Cell Transplantation | 1 | 2007 | 475 | 0.020 |
Why?
|
Interleukin Receptor Common gamma Subunit | 1 | 2004 | 89 | 0.010 |
Why?
|
Interleukin-9 | 1 | 2004 | 62 | 0.010 |
Why?
|
Immunoglobulins | 2 | 2000 | 854 | 0.010 |
Why?
|
Gene Silencing | 1 | 2011 | 1505 | 0.010 |
Why?
|
Antibody Specificity | 2 | 1998 | 1065 | 0.010 |
Why?
|
Vaccinia | 1 | 2004 | 71 | 0.010 |
Why?
|
Focal Adhesions | 1 | 2004 | 113 | 0.010 |
Why?
|
Autocrine Communication | 1 | 2004 | 168 | 0.010 |
Why?
|
Interleukin-15 | 1 | 2004 | 186 | 0.010 |
Why?
|
Megakaryocytes | 1 | 2008 | 571 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 1991 | 4857 | 0.010 |
Why?
|
Immunoglobulin M | 2 | 2001 | 1527 | 0.010 |
Why?
|
Combined Modality Therapy | 3 | 2004 | 8535 | 0.010 |
Why?
|
Random Allocation | 1 | 1988 | 2396 | 0.010 |
Why?
|
Isoantibodies | 1 | 2007 | 681 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 1997 | 5799 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 2011 | 3618 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2018 | 9536 | 0.010 |
Why?
|
Tuberculin | 1 | 2002 | 64 | 0.010 |
Why?
|
Doxorubicin | 2 | 2004 | 2234 | 0.010 |
Why?
|
Platelet-Derived Growth Factor | 1 | 2004 | 617 | 0.010 |
Why?
|
Chlorambucil | 1 | 2001 | 42 | 0.010 |
Why?
|
Drug Monitoring | 1 | 2008 | 964 | 0.010 |
Why?
|
Hepatomegaly | 1 | 2001 | 84 | 0.010 |
Why?
|
Protein Kinase C | 1 | 2006 | 1207 | 0.010 |
Why?
|
Karyotyping | 1 | 2003 | 1176 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2014 | 39345 | 0.010 |
Why?
|
Lentivirus | 1 | 2004 | 518 | 0.010 |
Why?
|
Mumps | 1 | 2002 | 71 | 0.010 |
Why?
|
Salvage Therapy | 1 | 2008 | 1273 | 0.010 |
Why?
|
Blood Viscosity | 1 | 2001 | 125 | 0.010 |
Why?
|
Survival Analysis | 2 | 2007 | 10098 | 0.010 |
Why?
|
Splenomegaly | 1 | 2001 | 192 | 0.010 |
Why?
|
Cardiac Output, Low | 1 | 2001 | 192 | 0.010 |
Why?
|
Fibroblasts | 2 | 2004 | 4176 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2011 | 4904 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 1998 | 20218 | 0.010 |
Why?
|
Skin Tests | 1 | 2002 | 630 | 0.010 |
Why?
|
Neutrophils | 1 | 2013 | 3786 | 0.010 |
Why?
|
Translocation, Genetic | 2 | 1998 | 1390 | 0.010 |
Why?
|
Protein Isoforms | 1 | 2004 | 1715 | 0.010 |
Why?
|
Graft Survival | 1 | 2010 | 3887 | 0.010 |
Why?
|
Mice, Inbred NOD | 1 | 2003 | 1837 | 0.010 |
Why?
|
Binding, Competitive | 1 | 2000 | 1142 | 0.010 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2008 | 2061 | 0.010 |
Why?
|
Rabbits | 2 | 1996 | 4771 | 0.010 |
Why?
|
Mutation | 1 | 2023 | 30211 | 0.010 |
Why?
|
Embryonal Carcinoma Stem Cells | 1 | 1998 | 20 | 0.010 |
Why?
|
Binding Sites, Antibody | 1 | 1998 | 340 | 0.010 |
Why?
|
Antibodies, Blocking | 1 | 1998 | 250 | 0.010 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2001 | 681 | 0.010 |
Why?
|
Chromosomes, Human, Pair 18 | 1 | 1998 | 247 | 0.010 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 1998 | 285 | 0.010 |
Why?
|
Bone Marrow Cells | 1 | 2004 | 2414 | 0.010 |
Why?
|
Lymphocyte Count | 1 | 1999 | 794 | 0.010 |
Why?
|
Drug Delivery Systems | 1 | 2008 | 2230 | 0.010 |
Why?
|
Pregnancy | 1 | 2018 | 30260 | 0.010 |
Why?
|
Transplantation Chimera | 1 | 1999 | 594 | 0.010 |
Why?
|
Immunoglobulin Fc Fragments | 1 | 1998 | 287 | 0.010 |
Why?
|
Cell Aggregation | 1 | 1996 | 238 | 0.010 |
Why?
|
Adolescent | 6 | 2004 | 89155 | 0.010 |
Why?
|
Neoplasms, Second Primary | 1 | 2004 | 1061 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2004 | 6228 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2004 | 3428 | 0.010 |
Why?
|
Receptors, IgE | 1 | 1996 | 375 | 0.010 |
Why?
|
Oligoclonal Bands | 1 | 1994 | 17 | 0.010 |
Why?
|
DNA Damage | 2 | 1996 | 2470 | 0.010 |
Why?
|
Multigene Family | 1 | 1998 | 1081 | 0.010 |
Why?
|
Fatigue | 1 | 2001 | 1557 | 0.010 |
Why?
|
Epitope Mapping | 1 | 1995 | 301 | 0.010 |
Why?
|
Keratinocytes | 1 | 1998 | 876 | 0.010 |
Why?
|
Oligonucleotide Probes | 1 | 1993 | 416 | 0.010 |
Why?
|
Melanoma, Experimental | 1 | 1996 | 559 | 0.010 |
Why?
|
Phenotype | 2 | 2003 | 16723 | 0.010 |
Why?
|
Bone Marrow Examination | 1 | 1993 | 154 | 0.010 |
Why?
|
Cross Reactions | 1 | 1995 | 828 | 0.010 |
Why?
|
Risk | 1 | 2004 | 9609 | 0.010 |
Why?
|
Organ Specificity | 1 | 1996 | 1968 | 0.010 |
Why?
|
Biopsy | 2 | 1994 | 6786 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2008 | 6668 | 0.010 |
Why?
|
Rural Population | 1 | 2002 | 2325 | 0.010 |
Why?
|
Aged, 80 and over | 3 | 2004 | 59598 | 0.010 |
Why?
|
Hypersensitivity, Immediate | 1 | 1994 | 348 | 0.010 |
Why?
|
Immunoassay | 1 | 1994 | 746 | 0.010 |
Why?
|
Immunoglobulin A | 1 | 1994 | 991 | 0.010 |
Why?
|
DNA, Complementary | 1 | 1993 | 1989 | 0.010 |
Why?
|
Lymphoma | 1 | 1999 | 1897 | 0.010 |
Why?
|
Rats, Inbred Strains | 1 | 1991 | 2087 | 0.010 |
Why?
|
Hemorrhage | 1 | 2001 | 3467 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 2 | 1993 | 10757 | 0.010 |
Why?
|
Sequence Alignment | 1 | 1993 | 2178 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2004 | 14718 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 1996 | 21206 | 0.010 |
Why?
|
Antibody Formation | 1 | 1994 | 1392 | 0.010 |
Why?
|
Epithelium | 1 | 1993 | 1607 | 0.000 |
Why?
|
Injections, Intravenous | 1 | 1991 | 1377 | 0.000 |
Why?
|
Cerebral Cortex | 1 | 2004 | 5813 | 0.000 |
Why?
|
Platelet Count | 1 | 1991 | 787 | 0.000 |
Why?
|
Tissue and Organ Procurement | 1 | 1996 | 986 | 0.000 |
Why?
|
Physical Examination | 1 | 1993 | 1263 | 0.000 |
Why?
|
Severity of Illness Index | 1 | 2004 | 15944 | 0.000 |
Why?
|
Incidence | 1 | 2004 | 21532 | 0.000 |
Why?
|
Neurons | 1 | 2004 | 9518 | 0.000 |
Why?
|
Rats, Sprague-Dawley | 1 | 1996 | 8120 | 0.000 |
Why?
|
Polymerase Chain Reaction | 1 | 1993 | 6071 | 0.000 |
Why?
|
Child | 2 | 2004 | 80906 | 0.000 |
Why?
|
Immunohistochemistry | 1 | 1994 | 11068 | 0.000 |
Why?
|
Cohort Studies | 1 | 2002 | 41749 | 0.000 |
Why?
|
Diagnosis, Differential | 1 | 1993 | 13000 | 0.000 |
Why?
|
Pilot Projects | 1 | 1991 | 8740 | 0.000 |
Why?
|
Infant | 1 | 1999 | 36534 | 0.000 |
Why?
|
Child, Preschool | 1 | 1999 | 42665 | 0.000 |
Why?
|
Liver | 1 | 1990 | 7574 | 0.000 |
Why?
|
Retrospective Studies | 1 | 2001 | 81746 | 0.000 |
Why?
|